The Time to and Type of Pancreatic Cancer Recurrence after Surgical Resection: Is Prediction Possible?
- PMID: 30254003
- DOI: 10.1016/j.acra.2018.07.025
The Time to and Type of Pancreatic Cancer Recurrence after Surgical Resection: Is Prediction Possible?
Abstract
Rationale and objectives: To evaluate factors predicting pancreatic cancer recurrence, and to determine the most common appearance of tumor relapse.
Materials and methods: Ninety patients with recurrent pancreatic cancer were retrospectively included in the study. 74.4% had pancreatic head tumors (group 1) and 25.6% pancreatic body and/or tail tumor (group 2). The tumor localization, operative technique, TNM stage, the R-status, tumor grade, lymphovascular, and perineural invasion were recorded. Location of local tumor recurrence, lymph node recurrence, or organ metastases were analyzed on the basis of follow-up CT imaging.
Results: Mean recurrence time was 17.4 ± 13.2 months. The most common recurrence type was local recurrence (84.4%), followed by lymph node (15.5%), liver (14.4%), and lung metastasis (6.7%). The predominant site of local recurrence in pancreatic head tumors was close to superior mesenteric artery, common hepatic artery, and/or celiac artery (57.4%), followed by area defined by portal vein, inferior vena cava, CA or superior mesenteric artery (31.2%). Patients with pancreatic body and/or tail carcinoma had higher incidence (p = 0.003) of metastatic disease comparing to pancreatic head tumors, while resection margin was the most common type of local tumor recurrence, seen in 46.7% cases versus 8.2% of patients with pancreatic head tumors (p < 0.001).
Conclusion: The most common recurrence type in patients with resected pancreatic carcinoma was local recurrence along cardinal arteries. The localization of primary tumor influences the type of tumor relapse and site of local recurrence.
Keywords: Adenocarcinoma; Computed tomography; Pancreas; Recurrence.
Copyright © 2018 The Association of University Radiologists. Published by Elsevier Inc. All rights reserved.
Similar articles
-
CT diagnosis of recurrence after pancreatic cancer: is there a pattern?World J Gastroenterol. 2011 Mar 7;17(9):1126-34. doi: 10.3748/wjg.v17.i9.1126. World J Gastroenterol. 2011. PMID: 21448416 Free PMC article.
-
[The clinical impact of artery-first approach combined with vascular resection and reconstruction in the treatment of pancreatic head carcinoma].Zhonghua Zhong Liu Za Zhi. 2017 Mar 23;39(3):225-230. doi: 10.3760/cma.j.issn.0253-3766.2017.03.014. Zhonghua Zhong Liu Za Zhi. 2017. PMID: 28316225 Chinese.
-
Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Pancreatic Tumor Study Group.Ann Surg. 1996 Feb;223(2):154-62. doi: 10.1097/00000658-199602000-00007. Ann Surg. 1996. PMID: 8597509 Free PMC article.
-
Different clinical presentations of metachronous pulmonary metastases after resection of pancreatic ductal adenocarcinoma: Retrospective study and review of the literature.World J Gastroenterol. 2017 Sep 21;23(35):6420-6428. doi: 10.3748/wjg.v23.i35.6420. World J Gastroenterol. 2017. PMID: 29085191 Free PMC article. Review.
-
Successful resection of pancreatic metastasis from oesophageal squamous cell carcinoma: a case report and review of the literature.BMC Cancer. 2019 Apr 5;19(1):320. doi: 10.1186/s12885-019-5549-9. BMC Cancer. 2019. PMID: 30953505 Free PMC article. Review.
Cited by
-
Treatment of primary or recurrent non-resectable pancreatic cancer with proton beam irradiation combined with gemcitabine-based chemotherapy.Strahlenther Onkol. 2023 Nov;199(11):982-991. doi: 10.1007/s00066-023-02106-5. Epub 2023 Jul 10. Strahlenther Onkol. 2023. PMID: 37428207
-
Pancreatic ductal adenocarcinoma with synchronous and metachronous hepatic metastasis predicted by contrast-enhanced ultrasound.Quant Imaging Med Surg. 2023 Jun 1;13(6):3902-3914. doi: 10.21037/qims-22-1132. Epub 2023 Apr 24. Quant Imaging Med Surg. 2023. PMID: 37284072 Free PMC article.
-
Clinical value of extended lymphadenectomy in radical surgery for pancreatic head carcinoma at different T stages.World J Gastrointest Surg. 2022 Nov 27;14(11):1204-1218. doi: 10.4240/wjgs.v14.i11.1204. World J Gastrointest Surg. 2022. PMID: 36504521 Free PMC article.
-
Development and validation of a radiomics model of magnetic resonance for predicting liver metastasis in resectable pancreatic ductal adenocarcinoma patients.Radiat Oncol. 2023 May 10;18(1):79. doi: 10.1186/s13014-023-02273-w. Radiat Oncol. 2023. PMID: 37165440 Free PMC article. Clinical Trial.
-
Risk factors and survival prediction of pancreatic cancer with lung metastases: A population-based study.Front Oncol. 2022 Sep 21;12:952531. doi: 10.3389/fonc.2022.952531. eCollection 2022. Front Oncol. 2022. PMID: 36212473 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical